Evidence map›Paper›PMID 27790114›Full record

ArticleCase reports in dermatology

Bilateral Necrotizing Fasciitis of the Foot Associated with Group B Streptococcus.

Keitaro Fukuda, Misao Ryujin, Reiko Sakio, Satoshi Fukuzumi, Takanori Omae, Kazuhito Hayakawa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Keitaro FukudaDepartment of Dermatology, Teikyo University Chiba Medical Center, Ichihara, Japan.
Misao RyujinDepartment of Dermatology, Teikyo University Chiba Medical Center, Ichihara, Japan.
Reiko SakioDepartment of Plastic and Reconstructive Surgery, Teikyo University Chiba Medical Center, Ichihara, Japan.
Satoshi FukuzumiDepartment of Plastic and Reconstructive Surgery, Teikyo University Chiba Medical Center, Ichihara, Japan.
Takanori OmaeDepartment of Orthopedic Surgery, Teikyo University Chiba Medical Center, Ichihara, Japan.
Kazuhito HayakawaDepartment of Dermatology, Teikyo University Chiba Medical Center, Ichihara, Japan.
Teikyo University Chiba Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing fasciitis (NF) is a severe bacterial infection involving fascia and subcutaneous tissue. It generally affects upper or lower extremities unilaterally, and there are few reports of bilateral-extremity NF. Here, we report a case of a 43-year-old male with type 1 diabetes who had NF on the left foot and subsequently developed NF on the other foot 1 week later. The patient survived with antimicrobial therapy and bilateral below-knee amputation. As group B streptococcus (GBS) was isolated by blood culture and culture of excised tissues of both feet, bilateral GBS NF of the foot was diagnosed. GBS is a rare causative pathogen in NF; however, there have been two case reports of bilateral GBS NF of an extremity in which NF appeared on the opposite extremity 1 week after the primary site infection, as in our case. GBS was isolated from cultures of blood and excised tissues of both extremities in both cases. Together, these observations suggest that GBS has a potential to cause secondary NF at remote sites by hematogenous dissemination with approximately 1 week delay and thereby lead to bilateral NF.

Indexed as

DiabetesGroup B streptococcusLower extremityNecrotizing fasciitis, bilateral

Identifiers

PMID27790114
PMCPMC5073656
OpenAlexW2519511286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.